Frequency Exchange Corp. Appoints Gail Edgell To Advisory Board
(TheNewswire)
Vancouver, British Columbia –December 17, 2025 – TheNewswire - FrequencyExchange Corp. (TSXV: FREQ) (OTC: FRECF) (“Frequency Exchange” orthe “Company”) is pleased to announce theappointment of Gail Edgell to its Advisory Board.
Gail Edgell brings over 25 years of experience in thewellness industry, with leadership roles across corporate wellness,professional supplements, biotechnology startups, and integrativeclinical consulting. She has held strategic positions focused onmarket development, practitioner engagement, and education-basedcommercialization, contributing to consistent revenue growth acrossseveral companies.
Her career includes senior contributions at Designs forHealth, where she helped scale practitioner channel sales from$360,000 to $1.5 million in under three years, and at Bio-BotanicalResearch, where she launched a practitioner partnership model thatreached $1 million in annualized revenue within 90 days. Ms. Edgellhas also supported business development efforts at PanaceuticsNutrition, a biotech startup, and has advised numerous integrativehealth clinics on operational growth and patient educationstrategies
“Gail brings a deep understanding of the wellnesspractitioner ecosystem and how to build lasting commercial andeducational relationships in that space,” said Stephen Davis, CEO ofFrequency Exchange Corp. “Her insights will support our efforts toscale NIKKI’s reach into professional, consumer, and community-basedhealth channels.”
Ms. Edgell is also a published author, founder ofInside Out Wellness, and a former nonprofit executive who ledwellness-focused programs serving over 300 organizations andcommunities. She continues to collaborate with leading nutritioncompanies and healthcare educators to reimagine practitioner supportexperiences.
Frequency Exchange Corp. (TSXV: FREQ; OTC: FRECF) isthe parent company of FREmedica Technologies Inc., a developer andcommercializer of frequency-based digital wellness technologies. TheCompany’s flagship product, NIKKI, delivers programmable frequencywellness programs designed to support cellular communication andoverall wellbeing.
Originally developed to support those with Lymedisease, the NIKKI platform has evolved to address broader use cases,including sleep, pain, energy, immune support, and athletic recovery.The Company’s technology is supported by ongoing testing andquality-of-life evaluations.
For more information,please contact:
Frequency Exchange Corp. FREmedica Technologies Inc.
Stephen Davis Nicole Sullivan
CEO & Director President
250-732-7170 Nicole.sullivan@wearenikki.com
Cautionary Note Regarding Forward-Looking Information
Certain information contained herein constitutes“forward-looking information” under Canadian securitieslegislation. All statements, other than statements of historical fact,included in this news release are forward-looking statements thatinvolve risks and uncertainties. In particular, forward-lookinginformation includes, but is not limited to, statements with respectto the Company’s use of proceeds from the private placement.Generally, forward-looking information can be identified by the use offorward-looking terminology such as “will” or variations of suchwords and phrases or statements that certain actions, events orresults “will” occur. Forward-looking statements are based on theopinions and estimates of management as of the date such statementsare made and they are subject to known and unknown risks,uncertainties and other factors that may cause the actual results tobe materially different from those expressed or implied by suchforward-looking statements or forward-looking information. There canbe no assurance that such statements will prove to be accurate, asactual results and future events could differ materially from thoseanticipated in such statements. Readers should not place unduereliance on forward-looking statements and forward-lookinginformation. The forward-looking statements contained in this newsrelease are made as of the date of this news release and the Companywill not update any forward-looking statements or forward-lookinginformation that are incorporated by reference herein, except asrequired by applicable securities laws.
Additional information identifying risks anduncertainties is contained in filings by the Company with the Canadiansecurities regulators, which filings are available under theCompany’s profile on SEDAR+ at www.sedarplus.ca.
Neither the Exchange nor itsRegulation Services Provider (as that term is defined in policies ofthe Exchange) accepts responsibility for the adequacy or accuracy ofthis release.
Copyright (c) 2025 TheNewswire - All rights reserved.
NASDAQ: FREQ:CC
FREQ:CC Trading
-16.67% G/L:
$0.225 Last:
25,000 Volume:
$0.26 Open:



